Lipid A phosphate (Lipid A-P)

Lipid A is the highly conserved, hydrophobic anchor of lipopolysaccharide (LPS) located in the outer leaflet of the Gram-negative bacterial outer membrane (Raetz & Whitfield, 2002). The phosphate groups attached to the 1 and 4' positions of its glucosamine disaccharide backbone carry a strong negative charge, which is essential for membrane stability through the bridging of divalent cations like magnesium and calcium. These phosphate groups represent a critical therapeutic target for polycationic antibiotics, most notably the polymyxin class, including Polymyxin B and Colistin (Trimble et al., 2016). Upon binding, these drugs displace the stabilizing cations, causing a loss of membrane integrity, leakage of cytoplasmic contents, and bacterial cell death. Furthermore, Lipid A is the primary immunostimulatory component of LPS, recognized by the human TLR4/MD-2 receptor complex, making its structure central to the pathogenesis of sepsis and septic shock (Park & Lee, 2013). Resistance to targeting these phosphates often occurs through enzymatic modifications, such as the addition of phosphoethanolamine or 4-amino-4-deoxy-L-arabinose, which reduces the overall negative charge and prevents drug binding (Liu et al., 2016). Because of its essential role in membrane stability and its accessibility on the bacterial surface, targeting these phosphates remains a vital strategy against multidrug-resistant Gram-negative pathogens.

Other names

Lipid A 1,4'-bisphosphateLipopolysaccharide phosphate groupsEndotoxin phosphateLipid A 1-phosphateLipid A 4'-phosphate

Cationic drugs bind electrostatically to the negatively charged phosphate groups of Lipid A, displacing divalent cations (Mg2+ and Ca2+) that normally stabilize the lipopolysaccharide layer. This displacement leads to the disruption of the outer membrane, increased permeability, leakage of intracellular contents, and eventual bacterial cell death (Trimble et al., 2016).